PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,229,000 | +29.0% | 389,952 | +19.0% | 0.00% | – |
| Q2 2020 | $953,000 | +17.1% | 327,779 | +13.6% | 0.00% | – |
| Q1 2020 | $814,000 | -45.0% | 288,492 | -36.8% | 0.00% | – |
| Q4 2019 | $1,481,000 | -1.0% | 456,671 | -34.1% | 0.00% | – |
| Q3 2019 | $1,496,000 | -34.1% | 692,905 | -4.1% | 0.00% | -100.0% |
| Q2 2019 | $2,269,000 | +79.4% | 722,596 | +112.4% | 0.00% | – |
| Q1 2019 | $1,265,000 | +26.2% | 340,199 | -1.6% | 0.00% | – |
| Q4 2018 | $1,002,000 | +10.7% | 345,586 | +0.3% | 0.00% | – |
| Q3 2018 | $905,000 | +17.8% | 344,399 | +4.9% | 0.00% | – |
| Q2 2018 | $768,000 | -25.2% | 328,259 | -6.1% | 0.00% | – |
| Q1 2018 | $1,027,000 | -4.7% | 349,552 | -11.1% | 0.00% | – |
| Q4 2017 | $1,078,000 | -8.1% | 393,127 | +13.6% | 0.00% | – |
| Q3 2017 | $1,173,000 | +41.5% | 346,057 | +3.0% | 0.00% | – |
| Q2 2017 | $829,000 | -39.8% | 335,818 | -44.6% | 0.00% | – |
| Q1 2017 | $1,377,000 | +0.1% | 606,658 | -6.6% | 0.00% | – |
| Q4 2016 | $1,376,000 | +115.3% | 649,418 | +240.7% | 0.00% | – |
| Q3 2016 | $639,000 | -54.4% | 190,593 | -57.3% | 0.00% | -100.0% |
| Q2 2016 | $1,402,000 | -39.6% | 446,085 | -36.0% | 0.00% | 0.0% |
| Q1 2016 | $2,320,000 | -15.0% | 696,640 | -9.6% | 0.00% | 0.0% |
| Q4 2015 | $2,729,000 | -72.6% | 770,746 | -61.1% | 0.00% | -75.0% |
| Q3 2015 | $9,961,000 | -19.5% | 1,980,394 | +2.9% | 0.00% | -20.0% |
| Q2 2015 | $12,379,000 | -64.1% | 1,925,025 | -60.7% | 0.01% | -28.6% |
| Q1 2015 | $34,446,000 | +38.9% | 4,896,646 | +52.3% | 0.01% | -30.0% |
| Q4 2014 | $24,791,000 | -18.0% | 3,215,659 | -20.6% | 0.01% | -23.1% |
| Q3 2014 | $30,241,000 | -23.8% | 4,048,452 | -1.2% | 0.01% | -18.8% |
| Q2 2014 | $39,678,000 | +77.8% | 4,098,912 | +52.6% | 0.02% | +77.8% |
| Q1 2014 | $22,317,000 | +315.0% | 2,685,688 | +321.5% | 0.01% | +350.0% |
| Q4 2013 | $5,377,000 | +25.3% | 637,107 | +18.3% | 0.00% | 0.0% |
| Q3 2013 | $4,293,000 | -5.1% | 538,674 | -8.1% | 0.00% | 0.0% |
| Q2 2013 | $4,524,000 | – | 586,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |